Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats.

Suili YangXiaoshan ZhangYuzhen WangCongcong WenChenxiang WangZiye ZhouGuanyang Lin

Published in: Drug design, development and therapy (2021)

Dasatinib alters the pharmacokinetics of posaconazole. Attention should be paid to the unexpected risk of adverse clinical outcomes when posaconazole is co-administered with dasatinib.

Keyphrases

chronic myeloid leukemia
working memory
simultaneous determination
emergency department
mass spectrometry
liquid chromatography